The Effect of Laughter Yoga Applied to Nursing Students on Exam Anxiety and Spirituality
Condition(s) studied
Investigational drug(s) / intervention(s)
laughter yoga: Participants in the intervention group received laughter yoga sessions twice a week for a total of four weeks.
Study summary
This study is planned as a randomized controlled trial to determine the effect of laughter yoga on the exam anxiety and spirituality levels of nursing students. The research will be conducted with 100 second-year nursing students between 04.2025 and 06.2025. Students who meet the inclusion criteria will be randomized and divided into two groups: the experimental group (n=36) and the control group (n=36). All participating students will be administered the "Demographic Characteristics Form," "Exam Anxiety Scale," and "Spirituality Scale" (pre-test).
The experimental group will undergo laughter yoga sessions twice a week for 4 weeks, totaling 8 sessions.
The control group will only complete the "Demographic Characteristics Form," "Exam Anxiety Scale," and "Spirituality Scale" (pre-test). No intervention will be applied to the control group.
After the laughter yoga sessions are completed, both the experimental and control groups will complete the "Demographic Characteristics Form," "Exam Anxiety Scale," and "Spirituality Scale" (post-test).
The collected data will be analyzed using SPSS 22 software.
Eligibility
Primary outcome measure(s)
- Change in exam anxiety levels as measured by the Test Anxiety Scale — Baseline and post-intervention (Week 4)
Exam anxiety will be assessed using a validated Test Anxiety Scale before and after the 4-week laughter yoga intervention. The mean score difference between pre-test and post-test will be analyzed using paired samples t-test.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Kirikkale University | Kirikkale | Turkey |
More Kırıkkale University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06943430 on ClinicalTrials.gov ↗ ← All trials in Turkey